Post

New research · Ophthalmology
Cureus · 12h
Case reportCureus · 2026

Leber Hereditary Optic Neuropathy Caused by the Rare MT-ND1 m.3394T>C Mutation: A Case With Favorable Visual Prognosis and a Literature Review.

Paulina Mikulenaite, Alvita Vilkeviciute, Almina Stramkauskaite … Rasa Liutkeviciene
Read paper
OphthalmologyCase report

Idebenone therapy led to sustained visual acuity improvement in rare leber hereditary optic neuropathy mutation case

Leber Hereditary Optic Neuropathy Caused by the Rare MT-ND1 m.3394T>C Mutation: A Case With Favorable Visual Prognosis and a Literature Review.

Paulina Mikulenaite … Rasa Liutkeviciene
Cureus · 2026
Background

Leber hereditary optic neuropathy (leber hereditary optic neuropathy) is an inherited mitochondrial optic neuropathy characterized by acute or subacute painless central visual loss.

1.0
Results
1.0
vision sharpened and stayed improved for six years on treatment
More results

Most cases are associated with three primary mitochondrial DNA mutations; however, rare variants remain incompletely characterized.

Early diagnosis is essential for appropriate management and genetic counseling.

We report the case of a 51-year-old Lithuanian woman who presented with painless, progressive central visual loss.

More results

It underscores the importance of considering hereditary optic neuropathy in patients with painless visual loss and poor response to corticosteroids.

“
Conclusion

Further studies are needed to clarify genotype-phenotype correlations and treatment responsiveness in rare leber hereditary optic neuropathy-associated mutations.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving